期刊文献+

血清1,3-β-D-葡聚糖检测用于造血干细胞移植后患者侵袭性真菌感染诊断的界值初探 被引量:5

Investigation of the cutoff value of a serum 1,3-β-D-glucan assay for early diagnosis of invasive fungal infection in Chinese hematopoietic stem cell transplant recipients
原文传递
导出
摘要 目的评价血清1,3-β-D-葡聚糖(BG)浓度检测对我国造血干细胞移植(HSCT)后患者侵袭性真菌感染(IFI)早期诊断的意义并确定其界值。方法按我国IFI的诊断标准,采用Glucatell试剂盒对HSCT后拟诊IFI的36例患者血清标本(每周采血2次)进行BG浓度的检测(G实验)。根据临床回顾性诊断标准定义阳性和阴性病例,按不同G试验阳性标准计算其灵敏度、特异度,最终确定G试验在我国HSCT后患者IFI诊断的界值。结果按试验中所得的单次结果≥80ng/L或连续两次结果≥60ng/L作为界值,得出G试验的灵敏度、特异度、阳性和阴性预测值,结果分别为81.0%、81.8%、89.5%和69.2%(P=0.002),并以此作为G试验在我国HSCT后IFI诊断的界值。结论G试验在我国HSCT患者IFI诊断的界值与国外基本相同,是一种早期诊断IFI的快速、灵敏的检测方法,值得临床推广。 Objective To evaluate the significance of a serum 1,3-β-D-glucan (BG) assay for early diagnosis of invasive fungal infection (IFI) and determine its cutoff value in Chinese post-hematopoietic stem cell transplant (HSCT) recipients. Methods Serum BG levels were measured twice weekly by Glucatell kit (G-Test) in 36 post-HSCT patients with suspected IFI. The sensitivities and specificities of the assay for clinical proven IFI and non-IFI patients were calculated retrospectively according to different G-Test positive criteria and determined its cutoff. Results The sensitivity, specificity, positive and negative predictive values were 81.0% , 81.8% , 89.5% and 69.2% ( P = 0. 002) respectively, as the cutoff value was set at more than 80 ng/L once or 60 ng/L consecutively twice. Conclusion The cutoff value of G test in Chinese post HSCT patients basically is the same as specified in the instruction of the kit, and it is a quick and reliable method for early diagnosis of IFI.
作者 纪宇 黄晓军
出处 《中华血液学杂志》 CAS CSCD 北大核心 2008年第6期405-407,共3页 Chinese Journal of Hematology
基金 基金项目:首都医学发展科学基金(2005-1010) 国家863项目(2006AA02Z4A0)
关键词 1 3-β-D-葡聚糖 真菌感染 侵袭性 造血干细胞移植 1,3-β-D-glucan Fungal infection,invasive Hematopoietic stem cell transplantation
  • 相关文献

参考文献8

  • 1纪宇,刘代红,许兰平,刘开彦,黄晓军.血清半乳甘露聚糖检测对造血干细胞移植后患者侵袭性曲霉菌感染的诊断价值[J].中华血液学杂志,2007,28(2):83-86. 被引量:29
  • 2Pickering JW, Sant HW, Bowles CAP, et al. Evaluation of a 1,3- β-D-glucan assay for diagnosis of invaslve fungal infections. J Clin Microbiol, 2005, 43 : 5957-5962.
  • 3McLintock LA,Jones BL. Advances in the molecular and serological diagnosis of invasive fungal infection in haemato-oncology patients. Br J Haematol, 2004, 126: 289-297.
  • 4血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(修订版)[J].中华内科杂志,2007,46(7):607-610. 被引量:250
  • 5Obayashi T, Yoshida M, Moil T, et al. Plasma 1,3-β-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episode. Lancet, 1995, 345 : 17-20.
  • 6Obayashi T, Yoshida M, Tamura H, et al. Determination of plasma (1→3)-β-D-glucan: a new diagnostic aid to deep mycosis. J Med Vet Mycol, 1992, 30: 275-280.
  • 7Odabasi Z, Mattiuzzi G, Estey E, et al. β-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis, 2004, 39: 199 -205.
  • 8Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Muhicenter clinical evaluation of the ( 1→3 ) -beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis, 2005, 41 : 654-659.

二级参考文献12

  • 1黄晓军.血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2005,44(7):554-556. 被引量:423
  • 2王景枝,刘代红,许兰平,陈欢,刘开彦,黄晓军.伊曲康唑在异基因造血干细胞移植患者真菌感染中的应用[J].中华内科杂志,2007,46(1):29-31. 被引量:7
  • 3Marr KA,Carter RA,Boeckh M,et al.Invasive aspergillosis in allogeneic stem cell transplant recipients:changes in epidemiology and risk factors.Blood,2002,100:4358-4366.
  • 4Singh N,Paterson DL.Aspergillus infections in transplant recipients.Clin Microbiol Rev,2005,18:44-69.
  • 5Mennink-Kersten MA,Donnelly JP,Verweij PE.Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis.Lancet Infect Dis,2004,4:349-357.
  • 6Marr KA,Balajee SA,McLaughlin L,et al.Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis:variables that affect performance.J Infect Dis,2004,190:641-649.
  • 7Maertens J,Theunissen K,Verbeken E,et al.Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients.Br J Haematol,2004,126:852-860.
  • 8Walsh LTJ,Shoham S,Petraitiene R,et al.Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro,in vivo,and clinical properties of the drugantigen interaction.J Clin Microbiol,2004,42:4744-4748.
  • 9Mattei D,Rapezzi D,Mordini N,et al.False-positive aspergillus galactomannan enzyme-linked immunosorbent saasy results in vivo during amoxicillin-clavulanic acid treatment.J Clin Microbiol,2004,11:5362-5363.
  • 10Maschmeyer G.The changing epidemiology of invasive fungal infections:new threats.Int J Antimicrob Agents,2006,27 Suppl 1:3-6.

共引文献266

同被引文献29

  • 1黄晓军.血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2005,44(7):554-556. 被引量:423
  • 2卢洪洲,曹天高,周颖杰,尹有宽,潘孝彰,翁心华.乳胶凝集试验对新型隐球菌性脑膜炎诊断及治疗的意义[J].中华传染病杂志,2005,23(3):209-211. 被引量:45
  • 3吕沛华,赵蓓蕾,施毅.非培养方法对侵袭性真菌感染诊断价值的研究进展[J].中国感染与化疗杂志,2006,6(4):284-287. 被引量:7
  • 4吕沛华,赵蓓蕾,施毅,文昱婷.1,3-β-D葡聚糖检测诊断侵袭性真菌感染的临床价值[J].中华结核和呼吸杂志,2007,30(1):31-34. 被引量:50
  • 5Prentice HG, Kibbler CC, Prentice AG. Towards a targeted, riskbased, antifungal strategy in neutropenic patients. Br J Haematol, 2000, 110 (2): 273-284.
  • 6中华医学会重症医学分会.重症患者侵袭性真菌感染诊断和治疗指南.中华医学会第二届全国重症大会,成都,2007.
  • 7Pazos C, Ponton J, Del Palocio A. Contribution of (1,3)-β-D glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neurpenic aduh patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol, 2005, 43 ( 1 ) : 299-305.
  • 8Ellis M, A1 - Ramadi B, Finkelman M,et al. Assessment of the clinical utility of serial beta - D - glucan concentrations in patients with persistent neutropenic fever[ J ]. J Med Microbiol,2008,57 (Pt3) :287 - 295.
  • 9Persat F, Ranque S, Derouin F, et al. Contribution of the ( 1 - - > 3 ) - beta - D - glucan assay for diagnosis of invasive fungal infections [ J]. J Clin Microbiol,2008,46(3 ) :1009 -1013.
  • 10Odabasi Z, Mattiuzzi G, Estey E, et al. Beta - D - glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome [ J ]. Clin Infect Dis,2004,39 (2) : 199 - 205.

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部